Industry News
In Acute Myeloid Leukemia Study Pinpoints And Plugs Mechanism Of Cancer Cell Escape
Jan 20, 2012
A study published this week in the journal Leukemia identifies a mechanism that acute myeloid leukemia (AML) cells use to evade chemotherapy - and details how to close this escape route... Read More
Study Examines Drug Resistance In ALK Positive Lung Cancer
Jan 20, 2012
Scientists from the University of Colorado Cancer Center have once again advanced the treatment of a specific kind of lung cancer. The team has documented how anaplastic lymphoma kinase (ALK) positive advanced non-small cell lung cancer (NSCLC) becomes resistant to a drug targeting the abnormal protein in the cancer... Read More
For Early Detection Of Colorectal Cancer, New Test Offers Greater Accuracy
Jan 20, 2012
Results of two studies suggest that a new, investigational colorectal cancer screening test developed in a collaboration between Mayo Clinic and Exact Sciences Inc. of Madison, Wis., is highly accurate and significantly more sensitive than other noninvasive tests at detecting precancerous tumors (adenomas) and early-stage cancer... Read More
Aspirin Merits Testing For Prevention Of Cervical Cancer In HIV-Infected Women
Jan 20, 2012
Research conducted by NewYork-Presbyterian Hospital/Weill Cornell Medical Center global health investigators and cancer specialists in New York, Qatar and Haiti suggests that aspirin should be evaluated for its ability to prevent development of cervical cancer in HIV-infected women... Read More
The Mystery Of An Old Diabetes Drug That May Reduce Cancer Risk: Research Opens Exciting New Avenues In Cancer Prevention
Jan 20, 2012
In 2005, news first broke that researchers in Scotland found unexpectedly low rates of cancer among diabetics taking metformin, a drug commonly prescribed to patients with Type II diabetes. Many follow-up studies reported similar findings, some suggesting as much as a 50-per-cent reduction in risk... Read More
Researchers Uncover Mechanism By Which Melanoma Drug Accelerates Secondary Skin Cancers
Jan 20, 2012
Patients with metastatic melanoma taking the recently approved drug vemurafenib (Zelboraf®) responded well to the twice daily pill, but some of them developed a different, secondary skin cancer... Read More
Study Examines Drug Resistance In ALK Positive Lung Cancer
Jan 20, 2012
Scientists from the University of Colorado Cancer Center have once again advanced the treatment of a specific kind of lung cancer. The team has documented how anaplastic lymphoma kinase (ALK) positive advanced non-small cell lung cancer (NSCLC) becomes resistant to a drug targeting the abnormal protein in the cancer... Read More
Aspirin Merits Testing For Prevention Of Cervical Cancer In HIV-Infected Women
Jan 20, 2012
Research conducted by NewYork-Presbyterian Hospital/Weill Cornell Medical Center global health investigators and cancer specialists in New York, Qatar and Haiti suggests that aspirin should be evaluated for its ability to prevent development of cervical cancer in HIV-infected women... Read More
Novel Mechanism Of Glioblastoma Development Revealed
Jan 20, 2012
Most research on glioblastoma development, a complicated tumor of the brain with a poor prognosis, has focused on the gene transcription level, but scientists suggest that post-transcriptional regulation could be equally or even more important. In a recent report in Molecular Cancer Research, a journal of the American Association for Cancer Research, scientists led by Luiz O. F. Penalva, Ph.D... Read More
Oxygen Starvation Reverses Radiation-Induced Damage To Brain Tissue In Mouse Model
Jan 20, 2012
Treating brain tumors with whole brain radiation therapy can damage healthy brain tissue, but a new study in mice reveals that limiting the oxygen supply, or hypoxia, can alleviate some of the cognitive impairment caused by the radiation. The results are reported in the online journal PLoS ONE... Read More
Previous Page Next Page